Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer
Clinical trial NCT01212627 · TERMINATED
Trial details
- NCT number
- NCT01212627
- Sponsor
- Angela Taber MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.